These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29752938)

  • 1. HBV polymerase-derived peptide exerts an anti-HIV-1 effect by inhibiting the acetylation of viral integrase.
    Kim H; Lee SY; Choi YM; Kim BJ
    Biochem Biophys Res Commun; 2018 Jun; 501(2):541-546. PubMed ID: 29752938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between HIV-1 Rev and integrase proteins: a basis for the development of anti-HIV peptides.
    Rosenbluh J; Hayouka Z; Loya S; Levin A; Armon-Omer A; Britan E; Hizi A; Kotler M; Friedler A; Loyter A
    J Biol Chem; 2007 May; 282(21):15743-53. PubMed ID: 17403681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wikstroelide M potently inhibits HIV replication by targeting reverse transcriptase and integrase nuclear translocation.
    Zhang X; Huang SZ; Gu WG; Yang LM; Chen H; Zheng CB; Zhao YX; Wan DC; Zheng YT
    Chin J Nat Med; 2014 Mar; 12(3):186-93. PubMed ID: 24702804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Hepatitis B Virus-Derived Peptide Can Inhibit Infection of Human Lung Cells with SARS-CoV-2 in a Type-1 Interferon-Dependent Manner.
    Choi YM; Jeong H; Park U; Cho NH; Kim BJ
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34202029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide HIV-1 integrase inhibitors from HIV-1 gene products.
    Suzuki S; Urano E; Hashimoto C; Tsutsumi H; Nakahara T; Tanaka T; Nakanishi Y; Maddali K; Han Y; Hamatake M; Miyauchi K; Pommier Y; Beutler JA; Sugiura W; Fuji H; Hoshino T; Itotani K; Nomura W; Narumi T; Yamamoto N; Komano JA; Tamamura H
    J Med Chem; 2010 Jul; 53(14):5356-60. PubMed ID: 20586421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase.
    Quashie PK; Oliviera M; Veres T; Osman N; Han YS; Hassounah S; Lie Y; Huang W; Mesplède T; Wainberg MA
    J Virol; 2015 Mar; 89(6):3163-75. PubMed ID: 25552724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of peptide motifs against HIV-1 reverse transcriptase and integrase.
    Andréola ML
    Curr Pharm Des; 2009; 15(21):2508-19. PubMed ID: 19601847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.
    Christ F; Debyser Z
    Virology; 2013 Jan; 435(1):102-9. PubMed ID: 23217620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
    Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
    Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy.
    De Silva Feelixge HS; Stone D; Pietz HL; Roychoudhury P; Greninger AL; Schiffer JT; Aubert M; Jerome KR
    Antiviral Res; 2016 Feb; 126():90-8. PubMed ID: 26718067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttranslational acetylation of the human immunodeficiency virus type 1 integrase carboxyl-terminal domain is dispensable for viral replication.
    Topper M; Luo Y; Zhadina M; Mohammed K; Smith L; Muesing MA
    J Virol; 2007 Mar; 81(6):3012-7. PubMed ID: 17182677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LEDGIN-mediated Inhibition of Integrase-LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV.
    Vranckx LS; Demeulemeester J; Saleh S; Boll A; Vansant G; Schrijvers R; Weydert C; Battivelli E; Verdin E; Cereseto A; Christ F; Gijsbers R; Debyser Z
    EBioMedicine; 2016 Jun; 8():248-264. PubMed ID: 27428435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structural biology of HIV-1: mechanistic and therapeutic insights.
    Engelman A; Cherepanov P
    Nat Rev Microbiol; 2012 Mar; 10(4):279-90. PubMed ID: 22421880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyproline-containing collagen peptide derived from the skin of the Alaska pollack inhibits HIV-1 infection.
    Jang IS; Park SJ
    Mol Med Rep; 2016 Dec; 14(6):5489-5494. PubMed ID: 27878297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chicoric acid analogues as HIV-1 integrase inhibitors.
    Lin Z; Neamati N; Zhao H; Kiryu Y; Turpin JA; Aberham C; Strebel K; Kohn K; Witvrouw M; Pannecouque C; Debyser Z; De Clercq E; Rice WG; Pommier Y; Burke TR
    J Med Chem; 1999 Apr; 42(8):1401-14. PubMed ID: 10212126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in the development of inhibitors of human immunodeficiency virus (HIV) integrase for the management of HIV infection.
    Lin SS; Xu F; Liao PH; Yang CC
    Acta Virol; 2008; 52(4):197-207. PubMed ID: 19143475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel 3-hydroxypicolinamides as selective inhibitors of HIV-1 integrase-LEDGF/p75 interaction.
    Zhang FH; Debnath B; Xu ZL; Yang LM; Song LR; Zheng YT; Neamati N; Long YQ
    Eur J Med Chem; 2017 Jan; 125():1051-1063. PubMed ID: 27810592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
    Witvrouw M; Fikkert V; Pluymers W; Matthews B; Mardel K; Schols D; Raff J; Debyser Z; De Clercq E; Holan G; Pannecouque C
    Mol Pharmacol; 2000 Nov; 58(5):1100-8. PubMed ID: 11040059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.